You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.

View our list of the best stock brokerages

Other companies in Vir Biotechnology’s space includes: Precigen Inc (NASDAQ:PGEN), MoonLake Immunotherapeutics (NASDAQ:MLTX), Immatics NV (NASDAQ:IMTX), AnaptysBio Inc (NASDAQ:ANAB) and Mesoblast Ltd (NASDAQ:MESO).

Vir Biotechnology has a consensus price target of $27.67.

The stock price for Vir Biotechnology (NASDAQ: VIR) is $9.8404 last updated April 9, 2026 at 4:29 PM EDT.

There are no upcoming dividends for Vir Biotechnology.

Vir Biotechnology does not have any upcoming earnings scheduled.

There is no upcoming split for Vir Biotechnology.

Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.